BioInvent International AB (publ) (BOVNF)
USD 4.7
(0.0%)
USD 4.7
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 71.46 Million SEK | -77.35% |
| 2022 | 31.14 Million USD | 1359.35% |
| 2021 | 2.13 Million USD | -88.11% |
| 2020 | 17.94 Million USD | 79.27% |
| 2019 | 10 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 1.25 Million USD | 176.82% |
| 2024 Q1 | 554.98 Thousand SEK | -61.21% |
| 2024 Q2 | 4.61 Million SEK | -22.4% |
| 2023 Q1 | 1.55 Million USD | -20.94% |
| 2023 Q4 | 1.51 Million USD | -38.13% |
| 2023 FY | 7.05 Million USD | -77.35% |
| 2023 Q3 | 2.44 Million USD | 102.2% |
| 2023 Q2 | 1.2 Million USD | -22.44% |
| 2022 Q2 | 26.38 Million USD | 0.0% |
| 2022 FY | 31.14 Million USD | 1359.35% |
| 2022 Q4 | 1.97 Million USD | 22.63% |
| 2022 Q3 | 1.6 Million USD | -93.91% |
| 2021 FY | 2.13 Million USD | -88.11% |
| 2020 FY | 17.94 Million USD | 79.27% |
| 2019 FY | 10 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -376.438% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -2303607.286% |
| SQZ Biotechnologies Company | 9.79 Million USD | -629.641% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -510.465% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 40.003% |
| Mesoblast Limited | -35.16 Million USD | 303.199% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 209356.223% |
| Genus plc | 178.7 Million USD | 60.011% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -17322.501% |
| Marizyme, Inc. | 457.7 Thousand USD | -15512.997% |
| ContraFect Corporation | -154 Thousand USD | 46503.247% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 649745.455% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 143022.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -92995.452% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -108622.31% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 18541.501% |
| MultiCell Technologies, Inc. | 49.32 USD | -144892438.524% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -77.477% |
| EV Biologics, Inc. | 48.9 Thousand USD | -146037.014% |
| Q BioMed Inc. | -8988.00 USD | 795171.206% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -152.915% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 463410.425% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 67.533% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -101987.143% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 57613.42% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -114741.063% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 1443173.506% |
| Arch Therapeutics, Inc. | -2439.00 USD | 2930030.299% |
| IMV Inc. | -962.29 Thousand USD | 7526.078% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -50761.922% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 73382.059% |
| GB Sciences, Inc. | -624.00 USD | 11452183.333% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 83167.141% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.055% |
| Halberd Corporation | -208.00 USD | 34356350.0% |
| Enzolytics Inc. | 30.7 Thousand USD | -232611.346% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -5165.547% |
| SYBLEU INC | 11.69 Thousand USD | -610886.662% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -14712.627% |
| argenx SE | 1.1 Billion USD | 93.553% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 377.002% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -11474.806% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 82.551% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 807021.861% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -61.101% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 6359.877% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -7133.034% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -643.533% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 85325.823% |
| BioStem Technologies, Inc. | 15.42 Million USD | -363.285% |
| ONE Bio Corp. | 20.12 Million USD | -255.078% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 603910.731% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 148178.079% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -40374.06% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -40374.06% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 13989.137% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 11440.532% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 246517.241% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -15778.705% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 22466.02% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -1450.803% |
| Bioxytran, Inc. | -8285.00 USD | 862634.701% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 19258.445% |
| Neutra Corp. | 14.33 Thousand USD | -498407.15% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 87247.561% |
| PureTech Health plc | -1.6 Million USD | 4557.954% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 7237.278% |
| IXICO plc | 3.27 Million USD | -2085.352% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 10396.974% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 4090.006% |
| CSL Limited | 7.7 Billion USD | 99.073% |
| Cellectis S.A. | 18 Thousand USD | -396905.556% |